Mankind Pharma Limited (NSE:MANKIND)

Mankind Pharma Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	909,286	1,000,400	921,654	-	-	-
Market Cap Growth	-14.10%	8.54%	-	-	-	-
Enterprise Value	960,414	960,198	902,241	-	-	-
Last Close Price	2202.70	2423.79	2299.84	-	-	-
PE Ratio	51.74	50.25	48.18	-	-	-
Forward PE	39.41	45.13	43.88	-	-	-
PS Ratio	6.71	8.20	8.98	-	-	-
PB Ratio	5.86	6.87	9.63	-	-	-
P/TBV Ratio	-	-	12.00	-	-	-
P/FCF Ratio	38.65	51.24	50.17	-	-	-
P/OCF Ratio	31.64	41.45	42.82	-	-	-
PEG Ratio	2.47	2.64	1.91	-	-	-
EV/Sales Ratio	7.09	7.87	8.79	-	-	-
EV/EBITDA Ratio	29.54	32.12	35.87	-	-	-
EV/EBIT Ratio	39.52	39.89	41.96	-	-	-
EV/FCF Ratio	40.82	49.18	49.11	-	-	-
Debt / Equity Ratio	0.54	0.58	0.02	0.02	0.14	0.06
Debt / EBITDA Ratio	2.58	2.84	0.08	0.09	0.44	0.16
Debt / FCF Ratio	3.56	4.36	0.11	0.17	1.94	0.34
Asset Turnover	0.63	0.62	0.95	0.93	1.00	1.09
Inventory Turnover	2.24	2.01	2.17	1.84	1.69	1.77
Quick Ratio	0.76	0.73	2.05	1.14	0.65	1.78
Current Ratio	1.14	1.23	3.10	2.32	1.68	2.89
Return on Equity (ROE)	13.46%	16.62%	22.57%	18.79%	25.99%	30.30%
Return on Assets (ROA)	7.07%	7.58%	12.40%	10.53%	14.76%	17.37%
Return on Capital (ROIC)	8.60%	9.16%	15.29%	13.24%	18.56%	22.22%
Return on Capital Employed (ROCE)	11.10%	10.90%	21.80%	20.20%	28.10%	31.70%
Earnings Yield	1.93%	1.99%	2.08%	-	-	-
FCF Yield	2.59%	1.95%	1.99%	-	-	-
Payout Ratio	2.36%	-	-	-	-	-
Buyback Yield / Dilution	-2.35%	-0.88%	-0.14%	-0.00%	-	-
Total Shareholder Return	-2.25%	-0.88%	-0.14%	-0.00%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.